Flamingo Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1985.
1985 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Flamingo Pharmaceuticals Limited

Flamingo Pharmaceuticals Limited, a active public limited company, was established on 12 June 1985 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51900MH1985PLC036572. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹6.80 Cr.

Formerly known as Flamingo Impex Limited, Flamingo Impex P Limited. It upholds a compliant status. Employing 552 professional, Its leadership includes Sunil Kumar (Ceo), Parth Ashwin Thacker (Director), Chhotulal Rawa Bhagwat (Director). Past directors included Archana Shashikant Padwal, Sandip Keshav Pawar, Uday Anant Sawant. It holds ₹121.37 Cr open charges and ₹452.45 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 7/1, Corporate Park, Sion-Trombay Road, P.O.Box No. : 27257,, Chembur,, Mumbai, Maharashtra, 400071.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51900MH1985PLC036572

  • Registration Number

    036572

  • Incorporation Date

    12 June 1985

  • Authorized Capital

    ₹10.00 Cr

  • Paid-Up Capital

    ₹6.80 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 6.80 Cr
  • Company Age 40 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 121.37 Cr
  • Satisfied Charges ₹ 452.45 Cr
  • Revenue Growth **** 31.44%
  • Profit Growth **** 5.61%
  • Ebitda **** -1.34%
  • Net Worth 9.94%
  • Total Assets **** 7.32%
Company report

Flamingo Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Flamingo Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Flamingo Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Sunil Kumar Ceo 02 Aug 2023 Current
Parth Ashwin Thacker Director 10 Nov 2023 Current
Chhotulal Rawa Bhagwat Director 25 Oct 2022 Current
Pranay Ashwin Thacker Director 08 Jun 2021 Current
Ashwin Jethalal Thacker Director 23 Jun 1986 Current
Meena Sanjiv Kapadi Director 28 Sep 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary 23 Sep 2021 Past
Pramod Abcsdd Director 28 Sep 2022 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary 03 May 2018 Past
Pramod Abcsdd Director 27 Feb 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Flamingo Pharmaceuticals.

Flamingo Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.44% increase. The company also saw a slight improvement in profitability, with a 5.61% increase in profit. The company's net worth moved up by a moderate rise of 9.94%.

Flamingo Pharmaceuticals revenue growth over time
Flamingo Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 31.44%
*******
*******
*******
*******
Revenue from Operations
*******
 28.02%
*******
*******
*******
*******
Total Assets
*******
 7.32%
*******
*******
*******
*******
Profit or Loss
*******
 5.61%
*******
*******
*******
*******
Net Worth
*******
 9.94%
*******
*******
*******
*******
EBITDA
*******
 -1.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Flamingo Pharmaceuticals?

In 2023, Flamingo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,213,700,000.00

Satisfied Charges

₹4,524,542,097.00

Charges Breakdown by Lending Institutions
  • Others : 104.37 Cr
  • Icici Bank Limited : 17.00 Cr
Latest Charge Details
Date Lender Amount Status
27 Feb 2023 Others ₹2.20 M Open
18 Nov 2022 Others ₹18.15 Cr Open
22 Feb 2022 Others ₹20.00 Cr Open
09 Oct 2015 Others ₹13.00 Cr Open
29 Sep 2015 Others ₹5.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Flamingo Pharmaceuticals?

Flamingo Pharmaceuticals has a workforce of 552 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Flamingo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Flamingo Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Flamingo Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Flamingo Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Director Appointment

    The activity Ashish Tayal was appointed as a Cfo was appointed as a Cfo on 24 Apr 2025 & has been associated with this company since 9 months 20 days . was completed.

  • Balance Sheet

    Progress on Flamingo Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    The activity A charge registered on 24 Jan 2024 via Charge ID 100923017 with Yes Bank Limited was fully satisfied on 17 Oct 2024. was completed.

  • Charges

    A charge with Others of Rs. 43.00 Cr registered on 18 Jun 2014 with Charge ID 10504887 was modified on 20 Jul 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Yes Bank Limited amounted to Rs. 20.00 Cr with Charge ID 100923017 was registered on 24 Jan 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Flamingo Pharmaceuticals Limited?

The CIN of Flamingo Pharmaceuticals Limited is U51900MH1985PLC036572.

Where is Flamingo Pharmaceuticals Limited headquartered?

Flamingo Pharmaceuticals Limited is headquartered at 7/1, Corporate Park, Sion-Trombay Road, P.O.Box No. : 27257,, Chembur,, Mumbai, Maharashtra, 400071.

When was Flamingo Pharmaceuticals Limited incorporated?

Flamingo Pharmaceuticals Limited was incorporated on 12 June 1985.

Who are the current directors of Flamingo Pharmaceuticals Limited?

The current directors of Flamingo Pharmaceuticals Limited are

What is the primary industry of Flamingo Pharmaceuticals Limited?

The primary industry of Flamingo Pharmaceuticals Limited is Manufacturing.

Is Flamingo Pharmaceuticals Limited a listed company?

Flamingo Pharmaceuticals Limited is unlisted.

What is the capital structure of Flamingo Pharmaceuticals Limited?

The authorized capital of Flamingo Pharmaceuticals Limited is ₹10.00 Cr, and the paid-up capital is ₹6.80 Cr.

What is the compliance status of Flamingo Pharmaceuticals Limited?

The compliance status of Flamingo Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available